🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

TOMORROW – Join our #RareDiseaseDay event livestream! Hear powerful stories from those living with a #raredisease, plus advocacy talks, educational sessions & more. See the agenda & register: eventcreate.com/e/rocket-pharm…

Today is the day! Don’t miss our livestreamed panel on #DanonDisease, a spotlight on RTW Charitable Foundation's impact, patient advocacy talks, and expert discussions on genetic testing and future therapies. Register: eventcreate.com/e/rocket-pharm… #RareDiseaseDay

In honor of #RareDiseaseDay, #TeamRocket CEO Gaurav Shah and President, Head R&D and COO Kinnari Patel met at the NYSE 🏛 to discuss our pursuit of #GeneTherapy cures. Watch below and join us in working toward a future where DNA is no longer destiny. youtu.be/QnIzduHB1Fg?si…

Our #RareDiseaseDay event was filled with powerful stories and impactful discussions. Thank you to all participants who drive progress in the #RareDisease community. To keep the momentum, #LightUpForRare today at 7 p.m.! Hang lights & decorate with theme colors to show support.

We’re thrilled to have rung the opening bell at Nasdaq on #RareDiseaseDay! We’re overwhelmed with gratitude at the opportunity to commemorate this important day & show our dedication, commitment, & mission to seek gene therapy cures for patients with devastating rare diseases.

The NYSE lights the façade to raise awareness for #RareDiseaseDay in collaboration with Rocket Pharmaceuticals!

Seeing major buildings lit up in support of #LightUpForRare for #RareDiseaseDay was incredibly inspiring. Thank you to all who participated— together, we’re spreading awareness and sparking change. Let’s continue lighting the way for #RareDisease advocacy and progress!

We’re onsite at the Rare Diseases Clinical Research Network Primary Immune Deficiency Treatment Consortium. As bronze level sponsors, we’re joining others working to improve outcomes for patients with rare, life-threatening, inherited disorders of the immune system.

From our live event, to ringing the Nasdaq bell, to lighting up Empire State Building, and much more, this #RareDiseaseDay was one to remember. Thank you for supporting our mission! Watch the replay: youtube.com/watch?v=FNjmfv… Danon Disease Foundation @RareDiseaseDay RTW Charitable Foundation Make-A-Wish New Jersey

We’re heading to #ACC25 this week! We’re looking forward to joining the latest industry research, drug development, and patient discussions as we progress three AAV #GeneTherapy programs that could impact +100k patients in the U.S. and EU. More: bit.ly/3R5o8RL

#TeamRocket is sharing poster presentations at two upcoming medical meetings: #AMCP2025 and #ISHLT2025. We look forward to connecting with fellow attendees and sharing our mission to fulfill the promise of #GeneTherapy for patients with devastating #RareDiseases. @AMCPorg The ISHLT

Next week, #TeamRocket President, Head of R&D, and COO Kinnari Patel, PharmD, MBA will join a panel at the Alliance for Regenerative Medicine (ARM) Cell & Gene Meeting on the Med. Learn more: meetingonthemed.com/agenda/

On April 22, #TeamRocket will host a webinar with Genetic Counselors on the potential of #GeneTherapy to provide a one-time treatment for inherited cardiomyopathies, including #Danon disease, featuring Jonathan Schwartz, Chief Medical & Gene Therapy Officer. ow.ly/sNuF50Vot8b

At #WorldOrphanUSA, #TeamRocket President, Head of R&D, and COO Kinnari Patel, PharmD, MBA, joins the keynote panel on the future of #RareDisease R&D to bring innovative therapies to people with rare diseases. More: terrapinn.com/conference/wor…

#WorldPIWeek 2025 is here! #TeamRocket is committed to raising awareness about Primary Immunodeficiencies (PI) and supporting the global PI community. We're advancing #GeneTherapy to offer hope for those impacted by #RareDiseases like LAD-I. Learn more: rocketpharma.com/patients-and-c…

This #NationalDNADay we celebrate the impact of genomics on modern medicine. #TeamRocket is on a mission to seek gene therapy cures for patients with devastating #RareDiseases through the most innovative science and platforms. rocketpharma.com/our-science/ #DNADay #Genetics #Genomics

This #FanconiAnemia Awareness Month, #FCF2025, #TeamRocket stands with patients and caregivers impacted by Fanconi anemia and remains committed to understanding their experience and advancing investigational new medicines. See below for more and in full: youtube.com/watch?v=3EYtwl…

#TeamRocket is looking forward to the ASGCT annual meeting next week! We will present preliminary Phase 1 data for plakophilin-2 related arrhythmogenic cardiomyopathy (PKP2-ACM) in a late-breaking oral presentation. Learn more: bit.ly/4kbVCu7. #ASGCT2025

#News from #ASGCT2025: #TeamRocket presents preliminary data for the first time from the Phase 1 study of RP-A601, an investigational #GeneTherapy for the treatment of plakophilin-2 related arrhythmogenic cardiomyopathy (PKP2-ACM). Learn more: bit.ly/4dmJTXx.

Thanks to all who joined our webinar with Genetic Counselors on the power of #GeneticTesting and counseling for those impacted by inherited, #RareDiseases like #DanonDisease. Watch the replay: youtube.com/watch?v=k3R6nc….